This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Cui MF, Chen LM, Jiang C, Ma BZ, Yuan FW, Zhao C, et al. Risks associated with cognitive function and management strategies in the clinical use of ADT: a systematic review from clinical and preclinical studies. Support Care Cancer. 2024 Jul 31;32(8):561.CuiMFChenLMJiangCMaBZYuanFWZhaoCRisks associated with cognitive function and management strategies in the clinical use of ADT: a systematic review from clinical and preclinical studiesSupport Care Cancer2024Jul31328561Search in Google Scholar
Mirzaei A, Deyhimfar R, Azodian Ghajar H, Mashhadi R, Noori M, Dialameh H, et al. Quercetin can be a more reliable treatment for metastatic prostate cancer than the localized disease: An in vitro study. J Cell Mol Med. 2023 May 26;27(12):1725–34.MirzaeiADeyhimfarRAzodian GhajarHMashhadiRNooriMDialamehHQuercetin can be a more reliable treatment for metastatic prostate cancer than the localized disease: An in vitro studyJ Cell Mol Med2023May262712172534Search in Google Scholar
Yang X, Chen H, Xu D, Chen X, Li Y, Tian J, et al. Efficacy and safety of Androgen Deprivation Therapy (ADT) combined with modified docetaxel chemotherapy versus ADT combined with standard docetaxel chemotherapy in patients with metastatic castration-resistant prostate cancer: study protocol for a multicentre prospective randomized controlled trial. BMC Cancer. 2022 Feb 16;22:177.YangXChenHXuDChenXLiYTianJEfficacy and safety of Androgen Deprivation Therapy (ADT) combined with modified docetaxel chemotherapy versus ADT combined with standard docetaxel chemotherapy in patients with metastatic castration-resistant prostate cancer: study protocol for a multicentre prospective randomized controlled trialBMC Cancer2022Feb1622177Search in Google Scholar
Zhang B, Yao K, Cheng C. A network-based integration for understanding racial disparity in prostate cancer. Transl Oncol. 2022 Jan 5;17:101327.ZhangBYaoKChengCA network-based integration for understanding racial disparity in prostate cancerTransl Oncol2022Jan517101327Search in Google Scholar
Bégay V, Cirovic B, Barker AJ, Klopfleisch R, Hart DW, Bennett NC, et al. Immune competence and spleen size scale with colony status in the naked mole-rat. Open Biol. 12(4):210292.BégayVCirovicBBarkerAJKlopfleischRHartDWBennettNCImmune competence and spleen size scale with colony status in the naked mole-ratOpen Biol124210292Search in Google Scholar
Licitra F, Giovannelli P, Di Donato M, Monaco A, Galasso G, Migliaccio A, et al. New Insights and Emerging Therapeutic Approaches in Prostate Cancer. Front Endocrinol (Lausanne). 2022 Feb 11;13:840787.LicitraFGiovannelliPDi DonatoMMonacoAGalassoGMigliaccioANew Insights and Emerging Therapeutic Approaches in Prostate CancerFront Endocrinol (Lausanne)2022Feb1113840787Search in Google Scholar
Rupp NJ, Freiberger SN, Ferraro DA, Laudicella R, Heimer J, Muehlematter UJ, et al. Immunohistochemical ERG positivity is associated with decreased PSMA expression and lower visibility in corresponding [68Ga]Ga-PSMA-11 PET scans of primary prostate cancer. Eur J Nucl Med Mol Imaging. 2024 Jul 31;RuppNJFreibergerSNFerraroDALaudicellaRHeimerJMuehlematterUJImmunohistochemical ERG positivity is associated with decreased PSMA expression and lower visibility in corresponding [68Ga]Ga-PSMA-11 PET scans of primary prostate cancerEur J Nucl Med Mol Imaging2024Jul31Search in Google Scholar
Gan J, Zeng X, Wang X, Wu Y, Lei P, Wang Z, et al. Effective Diagnosis of Prostate Cancer Based on mRNAs From Urinary Exosomes. Front Med (Lausanne). 2022 Mar 23;9:736110.GanJZengXWangXWuYLeiPWangZEffective Diagnosis of Prostate Cancer Based on mRNAs From Urinary ExosomesFront Med (Lausanne)2022Mar239736110Search in Google Scholar
Cheng HH, Shevach JW, Castro E, Couch FJ, Domchek SM, Eeles RA, et al. BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients: A Review. JAMA Oncol. 2024 Jul 25;ChengHHShevachJWCastroECouchFJDomchekSMEelesRABRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients: A ReviewJAMA Oncol2024Jul25Search in Google Scholar
Golubnitschaja O, Kubatka P, Mazurakova A, Samec M, Alajati A, Giordano FA, et al. Systemic Effects Reflected in Specific Biomarker Patterns Are Instrumental for the Paradigm Change in Prostate Cancer Management: A Strategic Paper. Cancers (Basel). 2022 Jan 28;14(3):675.GolubnitschajaOKubatkaPMazurakovaASamecMAlajatiAGiordanoFASystemic Effects Reflected in Specific Biomarker Patterns Are Instrumental for the Paradigm Change in Prostate Cancer Management: A Strategic PaperCancers (Basel)2022Jan28143675Search in Google Scholar
Nzombe L, Shirinde J, Patrick S. Insights into prostate cancer awareness and perceptions among men in Tshwane. S Afr Med J. 2024 Jun 24;114(6b):e1307.NzombeLShirindeJPatrickSInsights into prostate cancer awareness and perceptions among men in TshwaneS Afr Med J2024Jun241146be1307Search in Google Scholar
Pandit AA, Patil NN, Mostafa M, Kamel M, Halpern MT, Li C. Rural–Urban Disparities in Patient Care Experiences among Prostate Cancer Survivors: A SEER-CAHPS Study. Cancers (Basel). 2023 Mar 23;15(7):1939.PanditAAPatilNNMostafaMKamelMHalpernMTLiCRural–Urban Disparities in Patient Care Experiences among Prostate Cancer Survivors: A SEER-CAHPS StudyCancers (Basel)2023Mar231571939Search in Google Scholar
Rangel-Pozzo A, Liu S, Wajnberg G, Wang X, Ouellette RJ, Hicks GG, et al. Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level. Cells. 2020 Aug 8;9(8):1863.Rangel-PozzoALiuSWajnbergGWangXOuelletteRJHicksGGGenomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell LevelCells2020Aug8981863Search in Google Scholar
Sun H, Sun R, Song X, Gu W, Shao Y. Mechanism and clinical value of exosomes and exosomal contents in regulating solid tumor radiosensitivity. J Transl Med. 2022 Apr 28;20:189.SunHSunRSongXGuWShaoYMechanism and clinical value of exosomes and exosomal contents in regulating solid tumor radiosensitivityJ Transl Med2022Apr2820189Search in Google Scholar
Cheng YT, Huang CY, Chen CH, Chiu ST, Hong JH, Pu YS, et al. Preoperative %p2PSA and Prostate Health Index Predict Pathological Outcomes in Patients with Prostate Cancer Undergoing Radical Prostatectomy. Sci Rep. 2020 Jan 21;10:776.ChengYTHuangCYChenCHChiuSTHongJHPuYSPreoperative %p2PSA and Prostate Health Index Predict Pathological Outcomes in Patients with Prostate Cancer Undergoing Radical ProstatectomySci Rep2020Jan2110776Search in Google Scholar
Zeng YY, Gu Q, Li D, Li AX, Liu RM, Liang JY, et al. Immunocyte membrane-derived biomimetic nano-drug delivery system: a pioneering platform for tumour immunotherapy. Acta Pharmacol Sin. 2024 Jul 31;ZengYYGuQLiDLiAXLiuRMLiangJYImmunocyte membrane-derived biomimetic nano-drug delivery system: a pioneering platform for tumour immunotherapyActa Pharmacol Sin2024Jul31Search in Google Scholar
Han Y, Zou C, Liu T, Cheng W, Cheng P, Wu A. Inhibiting interferon-γ induced cancer intrinsic TNFRSF14 elevation restrains the malignant progression of glioblastoma. J Exp Clin Cancer Res. 2024 Jul 31;43(1):212.HanYZouCLiuTChengWChengPWuAInhibiting interferon-γ induced cancer intrinsic TNFRSF14 elevation restrains the malignant progression of glioblastomaJ Exp Clin Cancer Res2024Jul31431212Search in Google Scholar
Cari L, Sorrentino R, Akkaya B, Nocentini G. Editorial: Targeting regulatory cells in cancer: old and new approaches in immunotherapy. Front Immunol. 2024;15:1458280.CariLSorrentinoRAkkayaBNocentiniGEditorial: Targeting regulatory cells in cancer: old and new approaches in immunotherapyFront Immunol2024151458280Search in Google Scholar
Wang HC, Xia R, Chang WH, Hsu SW, Wu CT, Chen CH, et al. Improving cancer immunotherapy in prostate cancer by modulating T cell function through targeting the galectin-1. Front Immunol. 2024;15:1372956.WangHCXiaRChangWHHsuSWWuCTChenCHImproving cancer immunotherapy in prostate cancer by modulating T cell function through targeting the galectin-1Front Immunol2024151372956Search in Google Scholar
Somoza-Fernández B, Escudero-Vilaplana V, Collado-Borrell R, Pérez-Ramírez S, Villanueva-Bueno C, Montero-Antón MDP, et al. Severe neutropenia probably caused by enzalutamide and abiraterone in a prostate cancer patient. J Oncol Pharm Pract. 2024 Jul 23;10781552241264530.Somoza-FernándezBEscudero-VilaplanaVCollado-BorrellRPérez-RamírezSVillanueva-BuenoCMontero-AntónMDPSevere neutropenia probably caused by enzalutamide and abiraterone in a prostate cancer patientJ Oncol Pharm Pract2024Jul2310781552241264530.Search in Google Scholar
Al-Janabi H, Moyes K, Allen R, Fisher M, Crespo M, Gurel B, et al. Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapy. J Immunother Cancer. 2024 Jul 25;12(7):e009368.Al-JanabiHMoyesKAllenRFisherMCrespoMGurelBTargeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapyJ Immunother Cancer2024Jul25127e009368Search in Google Scholar
Lafta HA, AbdulHussein AH, Al-Shalah SAJ, Alnassar YS, Mohammed NM, Akram SM, et al. Tumor-associated Macrophages (TAMs) in Cancer Resistance; Modulation by Natural Products. Curr Top Med Chem. 2023;23(12):1104–22.LaftaHAAbdulHusseinAHAl-ShalahSAJAlnassarYSMohammedNMAkramSMTumor-associated Macrophages (TAMs) in Cancer Resistance; Modulation by Natural ProductsCurr Top Med Chem20232312110422Search in Google Scholar
Ahluwalia P, Mondal AK, Sahajpal NS, Rojiani MV, Kolhe R. Gene signatures with therapeutic value: emerging perspective for personalized immunotherapy in renal cancer. Immunotherapy. 2021 Dec;13(18):1535–47.AhluwaliaPMondalAKSahajpalNSRojianiMVKolheRGene signatures with therapeutic value: emerging perspective for personalized immunotherapy in renal cancerImmunotherapy2021Dec1318153547Search in Google Scholar
Sathish G, Monavarshini LK, Sundaram K, Subramanian S, Kannayiram G. Immunotherapy for lung cancer. Pathol Res Pract. 2024 Feb;254:155104.SathishGMonavarshiniLKSundaramKSubramanianSKannayiramGImmunotherapy for lung cancerPathol Res Pract2024Feb254155104Search in Google Scholar
Albittar AA, Alhalabi O, Glitza Oliva IC. Immunotherapy for Melanoma. Adv Exp Med Biol. 2020;1244:51–68.AlbittarAAAlhalabiOGlitzaOliva ICImmunotherapy for MelanomaAdv Exp Med Biol202012445168Search in Google Scholar
Wang Y, Su H, Lu Y, Li H. Regulatory Role of Fatty Acid Metabolism-Related Long Noncoding RNA in Prostate Cancer: A Computational Biology Study Analysis. J Oncol. 2023 Feb 14;2023:9736073.WangYSuHLuYLiHRegulatory Role of Fatty Acid Metabolism-Related Long Noncoding RNA in Prostate Cancer: A Computational Biology Study AnalysisJ Oncol2023Feb1420239736073Search in Google Scholar
Xu M, Zheng J, Hou T, Lin H, Wang T, Wang S, et al. SGLT2 Inhibition, Choline Metabolites, and Cardiometabolic Diseases: A Mediation Mendelian Randomization Study. Diabetes Care. 2022 Nov;45(11):2718–28.XuMZhengJHouTLinHWangTWangSSGLT2 Inhibition, Choline Metabolites, and Cardiometabolic Diseases: A Mediation Mendelian Randomization StudyDiabetes Care2022Nov4511271828Search in Google Scholar
Saw J, Yang ML, Trinder M, Tcheandjieu C, Xu C, Starovoytov A, et al. Chromosome 1q21.2 and additional loci influence risk of spontaneous coronary artery dissection and myocardial infarction. Nat Commun. 2020 Sep 4;11:4432.SawJYangMLTrinderMTcheandjieuCXuCStarovoytovAChromosome 1q21.2 and additional loci influence risk of spontaneous coronary artery dissection and myocardial infarctionNat Commun2020Sep4114432Search in Google Scholar
Zhang Y, Ou D hua, Zhuang D wu, Zheng Z feng, Lin M en. In silico analysis of the immune microenvironment in bladder cancer. BMC Cancer. 2020 Mar 30;20:265.ZhangYOuD huaZhuangD wuZhengZ fengLinM enIn silico analysis of the immune microenvironment in bladder cancerBMC Cancer2020Mar3020265Search in Google Scholar
Lu X, Li R, Ying Y, Zhang W, Wang W. Gene signatures, immune infiltration, and drug sensitivity based on a comprehensive analysis of m6a RNA methylation regulators in cervical cancer. J Transl Med. 2022 Sep 4;20:385.LuXLiRYingYZhangWWangWGene signatures, immune infiltration, and drug sensitivity based on a comprehensive analysis of m6a RNA methylation regulators in cervical cancerJ Transl Med2022Sep420385Search in Google Scholar
Cui S, Zhang M, Bai S, Bi Y, Cong S, Jin S, et al. Development of Prognostic Features of Hepatocellular Carcinoma Based on Metabolic Gene Classification and Immune and Oxidative Stress Characteristic Analysis. Oxid Med Cell Longev. 2023 Feb 18;2023:1847700.CuiSZhangMBaiSBiYCongSJinSDevelopment of Prognostic Features of Hepatocellular Carcinoma Based on Metabolic Gene Classification and Immune and Oxidative Stress Characteristic AnalysisOxid Med Cell Longev2023Feb1820231847700Search in Google Scholar
Zhao S, Chi H, Yang Q, Chen S, Wu C, Lai G, et al. Identification and validation of neurotrophic factor-related gene signatures in glioblastoma and Parkinson's disease. Front Immunol. 2023 Feb 7;14:1090040.ZhaoSChiHYangQChenSWuCLaiGIdentification and validation of neurotrophic factor-related gene signatures in glioblastoma and Parkinson's diseaseFront Immunol2023Feb7141090040Search in Google Scholar
Chen L, Zhang K, Sun J, Tang J, Zhou J. Development and Validation of an Autophagy-Stroma-Based Microenvironment Gene Signature for Risk Stratification in Colorectal Cancer. Onco Targets Ther. 2021 May 31;14:3503–15.ChenLZhangKSunJTangJZhouJDevelopment and Validation of an Autophagy-Stroma-Based Microenvironment Gene Signature for Risk Stratification in Colorectal CancerOnco Targets Ther2021May3114350315Search in Google Scholar
Zhang G, Lu J, Zheng J, Mei S, Li H, Zhang X, et al. Spi1 regulates the microglial/macrophage inflammatory response via the PI3K/AKT/mTOR signaling pathway after intracerebral hemorrhage. Neural Regen Res. 2023 May 31;19(1):161–70.ZhangGLuJZhengJMeiSLiHZhangXSpi1 regulates the microglial/macrophage inflammatory response via the PI3K/AKT/mTOR signaling pathway after intracerebral hemorrhageNeural Regen Res2023May3119116170Search in Google Scholar
Li W, Huang W, Li P, Wen Y, Shuai T, He Y, et al. Application of deep learning image reconstruction-high algorithm in one-stop coronary and carotid-cerebrovascular CT angiography with low radiation and contrast doses. Quant Imaging Med Surg. 2024 Feb 1;14(2):1860–72.LiWHuangWLiPWenYShuaiTHeYApplication of deep learning image reconstruction-high algorithm in one-stop coronary and carotid-cerebrovascular CT angiography with low radiation and contrast dosesQuant Imaging Med Surg2024Feb1142186072Search in Google Scholar
Shen Z, Zhao Z, Ren Q, Yan M. Female Off-Farm Employment and Fertility Timing in Rural China. Front Public Health. 2022 Mar 31;10:790436.ShenZZhaoZRenQYanMFemale Off-Farm Employment and Fertility Timing in Rural ChinaFront Public Health2022Mar3110790436Search in Google Scholar
O'Farrell F, Jiang X, Aljifri S, Pazoki R. Molecular Alterations Caused by Alcohol Consumption in the UK Biobank: A Mendelian Randomisation Study. Nutrients. 2022 Jul 19;14(14):2943.O'FarrellFJiangXAljifriSPazokiRMolecular Alterations Caused by Alcohol Consumption in the UK Biobank: A Mendelian Randomisation StudyNutrients2022Jul1914142943Search in Google Scholar
Yuan J, Xiong X, Zhang B, Feng Q, Zhang J, Wang W, et al. Genetically predicted C-reactive protein mediates the association between rheumatoid arthritis and atlantoaxial subluxation. Front Endocrinol (Lausanne). 2022 Dec 16;13:1054206.YuanJXiongXZhangBFengQZhangJWangWGenetically predicted C-reactive protein mediates the association between rheumatoid arthritis and atlantoaxial subluxationFront Endocrinol (Lausanne)2022Dec16131054206Search in Google Scholar
Marshall EA, Ng KW, Kung SHY, Conway EM, Martinez VD, Halvorsen EC, et al. Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis. Mol Cancer. 2016 Oct 27;15:67.MarshallEANgKWKungSHYConwayEMMartinezVDHalvorsenECEmerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasisMol Cancer2016Oct271567Search in Google Scholar
Sadeqi Nezhad M, Seifalian A, Bagheri N, Yaghoubi S, Karimi MH, Adbollahpour-Alitappeh M. Chimeric Antigen Receptor Based Therapy as a Potential Approach in Autoimmune Diseases: How Close Are We to the Treatment? Front Immunol. 2020 Nov 26;11:603237.Sadeqi NezhadMSeifalianABagheriNYaghoubiSKarimiMHAdbollahpour-AlitappehMChimeric Antigen Receptor Based Therapy as a Potential Approach in Autoimmune Diseases: How Close Are We to the Treatment?Front Immunol2020Nov2611603237Search in Google Scholar
Du X, Zhou Z, Shao Y, Qian K, Wu Y, Zhang J, et al. Immunoarchitectural patterns as potential prognostic factors for invasive ductal breast cancer. NPJ Breast Cancer. 2022 Feb 28;8:26.DuXZhouZShaoYQianKWuYZhangJImmunoarchitectural patterns as potential prognostic factors for invasive ductal breast cancerNPJ Breast Cancer2022Feb28826Search in Google Scholar
Jin Z, Wang M, Meng Y, Chen D, Xu Y, Jiang X, et al. Prognostic Implication of a Cuproptosis-Related miRNA Signature in Hepatocellular Carcinoma. J Healthc Eng. 2022 Sep 13;2022:4694323.JinZWangMMengYChenDXuYJiangXPrognostic Implication of a Cuproptosis-Related miRNA Signature in Hepatocellular CarcinomaJ Healthc Eng2022Sep1320224694323Search in Google Scholar
Franzolin G, Brundu S, Cojocaru CF, Curatolo A, Ponzo M, Mastrantonio R, et al. PlexinB1 inactivation reprograms immune cells in the tumor microenvironment, inhibiting breast cancer growth and metastatic dissemination. Cancer Immunol Res. 2024 Jun 14;FranzolinGBrunduSCojocaruCFCuratoloAPonzoMMastrantonioRPlexinB1 inactivation reprograms immune cells in the tumor microenvironment, inhibiting breast cancer growth and metastatic disseminationCancer Immunol Res2024Jun14Search in Google Scholar
Huang H, Li L, Luo W, Yang Y, Ni Y, Song T, et al. Lymphocyte percentage as a valuable predictor of prognosis in lung cancer. J Cell Mol Med. 2022 Apr;26(7):1918–31.HuangHLiLLuoWYangYNiYSongTLymphocyte percentage as a valuable predictor of prognosis in lung cancerJ Cell Mol Med2022Apr267191831Search in Google Scholar
Simon M, Stüve P, Schmidleithner L, Bittner S, Beumer N, Strieder N, et al. Single-cell chromatin accessibility and transposable element landscapes reveal shared features of tissue-residing immune cells. Immunity. 2024 Jul 17;S1074-7613(24)00321-2.SimonMStüvePSchmidleithnerLBittnerSBeumerNStriederNSingle-cell chromatin accessibility and transposable element landscapes reveal shared features of tissue-residing immune cellsImmunity2024Jul17S1074-7613(24)00321-2.Search in Google Scholar
He J, Chen Z, Xue Q, Sun P, Wang Y, Zhu C, et al. Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature. J Transl Med. 2022 Apr 25;20:186.HeJChenZXueQSunPWangYZhuCIdentification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signatureJ Transl Med2022Apr2520186Search in Google Scholar
Khalid K, Ahsan O, Khaliq T, Muhammad K, Waheed Y. Immunoinformatics-Based Proteome Mining to Develop a Next-Generation Vaccine Design against Borrelia burgdorferi: The Cause of Lyme Borreliosis. Vaccines (Basel). 2022 Aug 2;10(8):1239.KhalidKAhsanOKhaliqTMuhammadKWaheedYImmunoinformatics-Based Proteome Mining to Develop a Next-Generation Vaccine Design against Borrelia burgdorferi: The Cause of Lyme BorreliosisVaccines (Basel)2022Aug21081239Search in Google Scholar
Qin W, Gan F, Jike Y, Jiang M, Li A. Consensus Clustering and Survival-Related Genes of Cuproptosis in Cutaneous Melanoma. Mediators Inflamm. 2023 Feb 27;2023:3615688.QinWGanFJikeYJiangMLiAConsensus Clustering and Survival-Related Genes of Cuproptosis in Cutaneous MelanomaMediators Inflamm2023Feb2720233615688Search in Google Scholar
Fan X, Men R, Huang C, Shen M, Wang T, Ghnewa Y, et al. Critical roles of conventional dendritic cells in autoimmune hepatitis via autophagy regulation. Cell Death Dis. 2020 Jan 13;11(1):23.FanXMenRHuangCShenMWangTGhnewaYCritical roles of conventional dendritic cells in autoimmune hepatitis via autophagy regulationCell Death Dis2020Jan1311123Search in Google Scholar
Paul S, Chhatar S, Mishra A, Lal G. Natural killer T cell activation increases iNOS+CD206- M1 macrophage and controls the growth of solid tumor. J Immunother Cancer. 2019 Aug 6;7:208.PaulSChhatarSMishraALalGNatural killer T cell activation increases iNOS+CD206- M1 macrophage and controls the growth of solid tumorJ Immunother Cancer2019Aug67208Search in Google Scholar